Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...

A new topical treatment, Clascoterone, shows significant promise for male pattern baldness, offering a novel approach beyond existing options. Clinic ...

Doctors Ben and Sean Behnam built an alternative to one-size-fits-all solutions with their new company, Happy Head.

Male pattern baldness (androgenetic alopecia) is a common issue that can happen to men of all ages. It can cause diffuse hair loss across the entire scalp, a receding hairline, a bald patch, or a mix ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Female pattern hair loss is common during menopause.

Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company developing potentially ...

Many people in the U.S. are familiar with hair loss. About 30% to 50% of men will experience male-pattern baldness, or androgenetic alopecia, by the age of 50. The condition is characterized by ...

The OG of scalp-first haircare, Philip Kingsley's thickening shampoo is all about strengthening your hair from root to tip, ...

Most people experience hair loss because of androgenetic alopecia (pattern baldness), which at least in men, is highly genetic. We know much less about female pattern baldness. Male pattern baldness ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company developing potentially first-in-class therapeutics for common ...

Veradermics Completes Enrollment in its Phase 2/3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss, Advancing Development of the Potential First-Ever Extended-Release Oral Minoxidil ...